Carl Zeiss Meditec AG

AFXA

Company Profile

  • Business description

    Carl Zeiss Meditec is one of the largest visioncare technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up about 75% of sales in 2025, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.

  • Contact

    Goschwitzer Strasse 51-52
    JenaTH07745
    DEU

    T: +49 3641220115

    https://www.zeiss.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    30 September 2026

    Employees

    5,798

Stocks News & Analysis

stocks

SpaceX rally continues, expanding sky-high valuations

SpaceX has risen 50% from its IPO price to become the second-most-expensive stock under Morningstar’s coverage.
stocks

This US AI champion’s stock is too cheap to ignore

Even as competition looks likely to build, the company remains a leading wide-moat business securely at the center of the AI ecosystem.
stocks

Why SpaceX is coming to your Super Fund

Most Australians will end up owning SpaceX — whether they like it or not.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,047.3025.90-0.29%
CAC 408,467.9837.190.44%
DAX 4025,026.8092.130.37%
Dow JONES (US)51,564.7072.150.14%
FTSE 10010,399.70108.91-1.04%
HKSE23,924.81387.35-1.59%
NASDAQ26,517.93496.281.91%
Nikkei 22571,250.06196.570.28%
NZX 50 Index13,495.63132.320.99%
S&P 5007,500.5880.481.08%
S&P/ASX 2008,828.7027.90-0.32%
SSE Composite Index4,090.4817.59-0.43%

Market Movers